Table 4.
Per 1 unit increase in log(PTH) |
PTH≥65 vs <65 | |
---|---|---|
Over all No. | 1703 | 204 (12.0%) |
WMH volume change, cm3 | β coef (95% CI) | β coef (95% CI) |
Model 1 | 0.88 (−1.43, 3.19) | 1.48 (−0.56, 3.53) |
Model 2 | 1.09 (−1.27, 3.44) | 1.39 (−0.73, 3.51) |
Model 3 | 0.77 (−1.55, 3.09) | 0.92 (−1.21, 3.04) |
Model 4 | 1.21 (−1.31, 3.73) | 1.17 (−0.90, 3.24) |
P-interaction for race (Model 2) | P=0.32 | P=0.55 |
Incident infarcts (≥3 mm) | OR (95% CI) | OR (95% CI) |
Model 1 | 1.53 (1.01, 2.31) | 1.52 (1.05, 2.19) |
Model 2 | 1.50 (0.97, 2.30) | 1.42 (0.97, 2.06) |
Model 3 | 1.45 (0.90, 2.35) | 1.30 (0.86, 1.98) |
Model 4 | 1.61 (0.95, 2.72) | 1.37 (0.88, 2.13) |
P-interaction for race (Model 2) | P=0.06 | P=0.52 |
Model 1 (demographic variables): age, sex, race
Model 2 (demographic + behavioral and socioeconomic variables): Model 1 + education, body mass index, smoking status, alcohol drinking, physical activity
Model 3 (demographic + behavioral and socioeconomic + comorbidities): Model 2 + systolic and diastolic blood pressure, use of hypertension medication, diabetes, HDL cholesterol, total cholesterol, cholesterol lowering medications, and estimated glomerular filtration rate
Model 4: (demographic + behavioral and socioeconomic + comorbidities + mediators): Model 3 + 25(OH)D, calcium, phosphorus